GAP protocol

chemotherapy protocol consisting of gemcitabine (deoxycytine/aa) & above compounds; used in the treatment of peritoneal cancers

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

1.	Alagna, Alessandro: 1 article (03/2019)
2.	Briley, Annette: 1 article (03/2019)
3.	Copas, Andrew: 1 article (03/2019)
4.	Coxon, Kirstie: 1 article (03/2019)
5.	DESiGN Collaborative Group: 1 article (03/2019)
6.	Healey, Andrew: 1 article (03/2019)
7.	Johnson, Mark: 1 article (03/2019)
8.	Khalil, Asma: 1 article (03/2019)
9.	Lawlor, Deborah A: 1 article (03/2019)
10.	Lees, Christoph: 1 article (03/2019)

1.	Halitosis 10/01/2013 - "Twenty three (23) patients diagnosed with delusional halitosis were managed with the 'Stop-gap protocol' within the study period. " 10/01/2013 - "A 4-year prospective study of delusional halitosis patients managed with a 3-step 'Stop-gap protocol' is presented in this paper, to demonstrate our experience in applying the 'Stop-gap protocol'. " 10/01/2013 - "This article proposes a 'stop-gap protocol'for the initial management of delusional halitosis, which dental practitioners can apply where a multidisciplinary team of dentists and mental health experts (psychiatrist and psychologist) cannot be assembled. "
2.	Stillbirth 03/04/2019 - "Accurate information on the performance and service provision requirements of the GAP protocol has the potential to inform national policy decisions on methods to reduce the rate of stillbirth. "
3.	Leukocytosis (Pleocytosis) 12/01/1983 - "Duration of leukocytosis was 3.2 +/- .4 days for GAC patients and 4.9 +/- .9 days for those on the GAP protocol (P = 0.08). "